Mammals have three HP1 protein isotypes HP1β (CBX1), HP1γ (CBX3) and HP1α (CBX5) that are encoded by the corresponding genes Cbx1, Cbx3 and Cbx5. Recent work has shown that reduction of CBX3 protein in homozygotes for a hypomorphic allele (Cbx3 hypo ) causes a severe postnatal mortality with around 99% of the homozygotes dying before weaning. It is not known what the causes of the postnatal mortality are. Here we show that Cbx3 hypo/hypo conceptuses are significantly reduced in size and the placentas exhibit a haplo-insufficiency. Late gestation Cbx3 hypo/hypo placentas have reduced mRNA transcripts for genes involved in growth regulation, amino acid and glucose transport. Blood vessels within the Cbx3 hypo/hypo placental labyrinth are narrower than wild-type. Newborn Cbx3 hypo/hypo pups are hypoglycemic, the livers are depleted of glycogen reserves and there is almost complete loss of stored lipid in brown adipose tissue (BAT). There is a 10-fold reduction in expression of the BAT-specific Ucp1 gene, whose product is responsible for nonshivering themogenesis. We suggest that it is the small size of the Cbx3 hypo/hypo neonates, a likely consequence of placental growth and transport defects, combined with a possible inability to thermoregulate that causes the severe postnatal mortality.
Introduction
HP1 proteins are small adapter proteins that are constituents of larger complexes involved in a variety of nuclear functions (Canzio et al. 2014) . These include roles in heterochromatin formation, positive and negative transcriptional regulation, DNA repair, chromosome segregation and replication of heterochromatin (reviewed in Grewal and Elgin 2007; Billur et al. 2010) . In mammals, there are three HP1 isotypes, HP1β (CBX1), HP1γ (CBX3) and HP1α (CBX5), that are encoded by distinct genes, chromobox homolog 1 (Cbx1), Cbx3 and Cbx5, respectively (Jones et al. 2000) . The three HP1 isotypes possess extensive sequence similarity, but this similarity belies their nonredundant functions. The suggestion that the mammalian HP1 isotypes are likely to possess non-redundant functions came first from immunolocalization studies using isotypespecific antibodies. CBX1 and CBX5 proteins were found to be concentrated at sites of constitutive heterochromatin (Saunders et al. 1993; Wreggett et al. 1994) , while CBX3 was shown to have a more euchromatic distribution (Horsley et al. 1996) . It was suggested that its euchromatic distribution reflected the acquisition of new functions by CBX3 and subsequently it was shown that CBX3 is associated with euchromatic genes and is involved in elongation and processing of their mRNA transcripts (Vakoc et al. 2005; Hediger and Gasser 2006; Smallwood et al. 2012) .
Proof that HP1 isotypes were non-redundant came from mutational analyses. It was demonstrated that loss of CBX1 protein cannot be compensated by CBX3 and CBX5 proteins (Aucott et al. 2008) because the murine Cbx1 −/− mutation is perinatal lethal. Mortality is caused by respiratory failure due to defective post-synaptic differentiation in the diaphragm (Aucott et al. 2008) . In addition, while other organ systems seemed intact, Cbx1 −/− mutants exhibited defective development of the central nervous system that was associated with a profound genomic instability (Aucott et al. 2008) . Deletion of the CBX5 protein had no obvious effect. Cbx5 −/− mice are fully viable and fertile (cited in Aucott et al. 2008) , indicating a redundancy, most likely with CBX1. However, a recent study has shown that Cbx5 −/− mice exhibit a specific defect in the silencing of T H 1 expression in T H 2 cells (Allan et al. 2012) . These data show that CBX protein function(s) are likely to be overlapping, but there are non-redundant functions peculiar to each isotype that cannot be compensated and some of these functions may be quite specific in character.
Ablation of Cbx3 expression causes infertility in both sexes and a severe neonatal mortality (Brown et al. 2010; Abe et al. 2011; Takada et al. 2011 ). In one study, which used a hypomorphic Cbx3 allele (Cbx3 hypo ), roughly 99% of the homozygous mutants died before weaning, whereas on day 19 of fetal development (E19) normal Mendelian ratios of wild-type to targeted alleles were observed (Brown et al. 2010) . In all Cbx3 hypo/hypo tissues examined the levels of CBX3 protein were barely detectable (Brown et al. 2010) . The causes for the neonatal demise of Cbx3 hypo/hypo homozygotes are not known. Here we describe the cellular and molecular changes that take place in Cbx3 hypo/hypo conceptuses and newborns. Our findings indicate that the Cbx3 hypo/hypo mutation is pleiotropic and causes generalized defects in placental development and energy homeostasis that are together responsible for the postnatal mortality of Cbx3 hypo/hypo homozygotes.
Materials and methods

Mice and mouse tissues
All experiments with mice were conducted according to the guidelines issued by Uppsala University. The Cbx3 hypo allele, which has been described in detail in Brown et al. (2010) , was propagated as heterozygote in a mixed C57BL6/129 genetic background at the Borstel Research Center and subsequently at the animal facilities at the Biomedical Center, Uppsala, where the allele was crossed into a BALB/c background to backcross 3. No obvious differences could be observed between fetuses from matings with different strain combinations and consequently results are pooled. Pregnant females were killed by cervical dislocation, with the day of vaginal plug being counted as day 1. Fetuses and placentas were weighed. Placentas were halved, one half was frozen on dry ice for nucleic acid or protein extraction, while the other half was either fixed in Carnoy's fixative and later processed for paraffin histology, or embedded directly in Tissue-Tek O.C.T. Compound (Sakura) and used for cryo-sectioning. For determination of blood glucose levels, newborn mice were decapitated and blood glucose determined with a OneTouch UltraEasy glucose meter.
BrdU cell proliferation assay
Cellular proliferation in placental and fetal tissues was determined using the BrdU assay according to Jägerbauer et al. (1992) .
Staining of sections
Antibodies used were against smooth muscle actin (DAKO M0851) and BrdU (DAKO M0744), isolectin B4 was obtained from Vector laboratories (B-1205). Horseradish peroxidase-labelled secondary antibodies were obtained from DAKO and Vector laboratories. IHC was carried out according to standard procedures. Antigen retrieval was performed in a microwave at 480 W for 10 min in 10 mM citrate, 0.05% Tween20, pH 6.0. Frozen, 10% PFA postfixed sections were stained with Oil red O. Carnoy's fixed paraffin sections were stained with PAS. For counting of nuclei, pictures were taken at 40× magnification and quantified on a screen. Three randomly selected areas from at least 3 different fetuses were analysed.
DNA extraction and genotyping PCR
Genomic DNA was extracted from tissues using the Promega Wizard genomic DNA extraction kit. The following primers were used to genotype Cbx3 mutant mice: forward: 5′-AGTCCCAGTACTGAGAGTTC-3′ and reverse: 5′-CTCTACCTCCTGAGTACTAG-3′. Reaction conditions have been described previously (Brown et al. 2010) .
Lipid extraction and analysis
For placental transport analysis (Wu et al. 2003; Yu et al. 2008) , total lipid was extracted and purified from Cbx3 hypo/hypo and Cbx3 +/+ E13 and E18 fetuses and their placentas and the ratios of EFAs (20:4; 18:2; 22:6) to NEFAs (16:0; 18:0) were determined. BSTFA containing 1% TMCS was from Thermo (Runcorn, UK). All other chemicals were from Sigma Aldrich (Schnelldorf, Germany). A Scion TQ GC-MS system from Bruker (Bremen, Germany) equipped with a Bruker BR5-MS 15 m × 0.25 mm × 0.25 μm column was used. The injector was operated in splitless mode, held at 280°C. The injection volume was 1 μL and the oven program started and kept for 0.5 min at 90°C, ramped to 180 with 30°C/min, then to 250°C with 10°C/ min, then to 266°C with 2°C/min, and finally to 300°C with 120°C/min. Helium (99.9990%) was used as carrier gas at a flow rate of 1.2 mL/min. The retention times of all analytes were determined, so the selected ion monitoring (SIM) method could be programmed with a 0.30 min window for each compound.
For the analysis of the total lipid content, to~1 mL sample, 3 mL of methanol and 1 mL of 10 M NaOH were pipetted into a pre-cleaned glass 10 mL test-tube. Before closing the tube, the atmosphere in the vial was flushed with argon. The tube was placed in an oven for 1 h at 90°C. After cooling, 2 mL of 6 N of HCl were added, subsequently 10 μL internal standard (C16:0 d31) was added. Extraction was carried out by adding 3 mL of n-hexane. After shaking, the n-hexane layer was transferred to another tube. This was done three times, to ensure an optimal extraction. n-Hexane was added to the extract to 10 mL. 50 μL were taken from the extract and dried in an autosampler vial. Dried samples were derivatized by 25 μL of MtBSTFA for 10 min at room temperature and subsequently 25 μL of BSTFA and 2.5 μL of pyridine were added before putting the sample in an oven for 15 min at 50°C. 947.5 μL of n-hexane, containing 10 μg/mL octadecane (C18) internal standard, was used to dilute the sample, prior to injection.
Quantitative real-time RT-PCR (qRT-PCR)
Gene expression levels were analysed by quantitative real time PCR (Corbett Research RG-3000 thermo-cycler) for the growth regulatory genes (Grb10, Igf2, H19), the placentaspecific transcript of Igf2 (Igf2P0), the placental transporter genes of the system A family of amino acid transporters (Slc38a1, Slc38a2, Slc38a4), the predominant placental glucose transporters (Slc2a1, Slc2a3), the prolactin family genes (Prl, Prlr, Prl7b1, Prl3c1, Prl4a1, Prl8a9, Prl7c1), the key enzymes in glucose homeostasis (G6pc, Pck1, Gys2), and the genes related to lipid and mitochondrial metabolism (Pparg2, Srebp1, Pgc1a, Ucp1, Cs, Hmgcs). Total RNA was extracted from snap-frozen tissues with TRIzol reagent (Ambion Life Technologies) according to manufacturer's guide. DNase treatment was performed prior to cDNA synthesis with Promega's RQ1 RNase-Free Dnase Kit. cDNA was synthesized using high-capacity cDNA Reverse Transcription Kit of AppiledBiosystems. PowerSYBR® Green PCR Master Mix (Life Technologies) was used for real time PCR quantification of transcripts. All samples were analysed in triplicates and data were normalized using Delta Delta CT method (Livak and Schmittgen, 2001 ). Accordingly, the amplification efficiency of the constitutively expressed reference genes, Tubb, Actb and 28s rRNA, were compared of the amplification of the target genes of interest (given above) in order to find the optimal combination of reference gene and target gene for calculation of normalized expression as described by Livak and Schmittgen (2001 hypo/+ and wild-type placentas, weight differences were significant on E13 (P<0.005), E18 (P<0.01), and E19 (P<0.01). With regard to fetal weights, the weights of Cbx3 hypo/hypo fetuses were significantly reduced compared with both Cbx3 hypo/+ and Cbx3 +/+ fetuses from day 16 onwards (figure 1d). These data indicate that the reduced placental weights we observed from day 13 (figure 1c) could cause or contribute to the fetal growth restriction that follows. Cbx3 hypo/hypo fetuses showed no catch-up growth during late gestation unlike Cbx3 hypo/hypo placentas. Neither was there any significant weight difference between Cbx3 hypo/+ and Cbx3
fetuses at any stage (figure 1d), showing that the Cbx3 haplo-insufficiency was only in the placenta.
Effect of the Cbx3
hypo allele on proliferation in placental and fetal tissues It is known that differential cell proliferation is sufficient to explain growth phenotypes (Zechner et al. 2002) . To determine if reduced fetal and placental weights were caused by decreased cell proliferation, we performed anti-BrdU immunohistochemistry (IHC) and calculated the percentage of BrdU-positive nuclei.
With regard to fetuses there was clear evidence for decreased proliferation in Cbx3 hypo/hypo vs. Cbx3
tissues at E13, with 18.5±3.0% vs. 32.9±4.1% BrdU-positive nuclei in heart (figure 2a and b; P=0.001), 38.9±3.7% vs. 47.2±4.9% BrdU-positive nuclei in lung (P=0.001), and 27.7±2.9% vs. 31.2±1.6% in tongue (P<0.002). On E18 no significant difference could be observed between hearts of Cbx3 hypo/hypo and wild-type fetuses (22.5±0.76 vs. 23.0±0.99; P=0.57). Notably, at E18 the brown adipose tissue (BAT) of Cbx3 hypo/hypo fetuses exhibited significantly increased BrdU-incorporation compared to wild-type BAT (figure 2c and d; 16.7±5.3% vs. 6.8±4.7%; P<0.001).
With regard to the placenta, decreased proliferation was observed in the E13 Cbx3 hypo/hypo labyrinth, which ; P=0.09).
Placental morphology and function
Prompted by the observation that placental growth restriction presaged the onset of fetal growth restriction (figure 1) and may thus cause the fetal growth restriction, we decided to Cbx3 allele causes prenatal growth restriction and perinatal energy homeostasis defectsinvestigate placental morphology and function in more detail. We compared the placental morphology of Cbx3 hypo/hypo and wild-type placentas between E12 and E19 of gestation using hematoxylin and eosin (HE), an anti-smooth muscle actin (SMA) antibody and isolectin-B4 (BSB4) that marks the matrix surrounding fetal blood vessels (Wood et al. 1979; Kurz et al. 1999 ).
We did not observe any consistent alterations of placental morphology in early post-mid gestation Cbx3 hypo/hypo placentas, but we did observe some changes in late gestation Cbx3 hypo/hypo placentas. First, as shown in figure 3a to d, we observed increased staining, both in terms of the numbers of cells and staining intensity, of the SMA-positive pericytes. Apart from this enhanced staining of pericytes smooth muscle differentiation looked normal in late gestation Cbx3 hypo/hypo placentas. Second, there was decreased BSB4-staining (C.f. figure 3e with 3f) that was associated with decreased width of blood vessels. Third, we observed increased numbers of nuclei per given area in sections of late gestation Cbx3 hypo/hypo placentas compared to wild-type placentas. E18 and E19 Cbx3 hypo/hypo placental sections showed significantly higher nuclear density in the labyrinth compared to wild-type placentas (E18: 291±35.3 vs. 257±35.6; E19: 315±51 vs. 206±42; P<0.001; C.f. figure 3i with 3j). This contrasted to the situation found at E12 where nuclear density in the labyrinth was reduced in Cbx3 hypo/hypo compared to wild-type placentas (231±16 vs. 273±17; P=0.02; C.f. figure 3g with 3h) ; analysis of intervening stages showed that the tendency for reduced nuclear density in Cbx3 hypo/hypo labyrinth persisted until E14. These findings indicate that after E14 the Cbx3 hypo/ hypo placentas compensate by increasing cell number and thus the surface area for exchange of nutrient, gas and waste exchange between the fetal and maternal blood supplies.
We next measured changes in mRNA transcripts of genes whose expression is known to change during the placental growth restriction that results from undernourishment of dams (Coan et al. 2010) . They included placental growth regulators, amino acid and glucose transporters (figure 3k). In E19 Cbx3 hypo/hypo placentas expression of the placentaspecific transcript of Igf2, Igf2P0, and of Grb10 are reduced The nuclei of E12 to E19 placental sections from Cbx3 hypo/hypo and Cbx3 +/+ littermates were stained and counted. Comparing the number of nuclei in E12 Cbx3 hypo/hypo (g) placentas to that of Cbx3 +/+ (h) littermates showed that the nuclear density was reduced in E12 Cbx3 hypo/hypo placentas (number of placentas counted: hypo/hypo=2; +/+=2; 3 areas were analysed from each placenta). By contrast, E19 Cbx3 hypo/hypo placentas shown in (i) exhibited higher nuclear density in the labyrinth than Cbx3 +/+ littermates shown in (j) (number of placentas analysed: hypo/hypo=4; +/+=2; 3 areas were analysed from each placenta). (k) Normalized real time PCR transcripts of genes relevant to placental growth and transport function. mRNA transcripts in Cbx3 hypo/hypo placentas were measured on E19 (black, filled bars) and compared to Cbx3 +/+ transcript levels that were normalized to 1.0 (empty bars). Significant expression changes are indicated by asterisks (*p< 0.05; **p<0.01). Statistical significance was assessed by unpaired t-test. Cbx3
hypo/hypo gene expression levels are indicated by filled bars, Cbx3 +/+ levels, normalized to 1.0, by empty bars (number of placentas analysed: hypo/hypo=3; +/+=3). Magnification in (a, b) is ×10 and (c to j) is ×40 of the original.
to 78%and 70% of wild-type respectively. There was no significant change in expression of the growth regulator H19. E19 Cbx3 hypo/hypo placentas showed significantly reduced expression of mRNA transcripts in two of the three members of the system A amino acid transporter family, Slc38a1 (down to 80% of wt) and Slc38a2 (down to 78% of wt). There was no significant change in the expression of the Slc38a4 gene.There was a dramatic reduction in the mRNA transcript of placental glucose transporter gene, Slc2a3, to 58% of wild-type levels. The Slc2a1 mRNA transcript was also reduced to 83% of wild-type levels.
To directly test placental transport function we determined essential fatty acid (EFA) transport across the placenta. We used the method detailed in Wu et al. (2003) and Yu et al. (2008) We have previously shown that roughly 99% of Cbx3 hypo/hypo homozygotes on a mixed 129/Sv-C57BL/6 genetic background die before weaning, whereas during prenatal development normal Mendelian ratios of Cbx3 hypo to wild-type alleles were observed (Brown et al. 2010) . The nature and the timing of the postnatal attrition of Cbx3 hypo/hypo homozygotes was not determined (Brown et al. 2010) . A number (N=10) of post-partum (PP1) day 1 litters from Cbx3 hypo/+ × Cbx3 hypo/+ matings were analysed. The prenatal fetal weight restriction (figure 1) persisted in postnatal Cbx3 hypo/hypo pups. At PP1 Cbx3 hypo/hypo body weights were 79% of Cbx3 hypo/+ and Cbx3 +/+ combined (P<0.001; figure 1d ). When a PP8 litter consisting of four pups was analysed, body weights were 3,805 and 3,288 mg for Cbx3 hypo/hypo and 5,657 mg and 5,756 mg in a Cbx3 +/+ and a Cbx3 hypo/+ , respectively; Cbx3 hypo/hypo weights were 62% of wild-type. Reduced body weight had also been observed in the adult Cbx3 hypo/hypo mice described previously (Brown and Singh, unpublished) .
Stomachs of PP1 Cbx3 hypo/hypo pups frequently contained no milk (C.f. figure 4a with 4d) and most were found dead or dying at around noon of PP1at the periphery of the group/huddle of littermates. Death also occurred when competing wild-type and heterozygous littermates had been removed. Only three Cbx3 hypo/hypo pups survived beyond PP1: one pup died on PP2, and two pups from one litter were sacrificed on PP8 for analysis. The mortality of the Cbx3 hypo/hypo homozygotes was too early to be explained by non-feeding alone because non-feeding mice that do not suckle die within a time window of 12-24 h after birth (Turgeon and Meloche 2009) .
External examination of Cbx3 hypo/hypo pups provided no explanation for the severe neonatal mortality. Cbx3 hunch-back phenotype (Aucott et al. 2008) , nor any cyanosis. They also exhibited a normal righting reflex and were not anosmic. Internal examination of Cbx3 hypo/hypo , Cbx3 hypo/+ and control wild-type PP1 pups revealed no obvious malformation of organ systems necessary for postnatal survival, such as heart and kidneys. However, we consistently observed reduced vascularization of the intestines and the intrascapular BAT in Cbx3 hypo/hypo pups (not shown). Vascularization of the intestines largely occurs postnatally and is induced by milk uptake; notably, as shown in figure 4a and d, milk was frequently absent from the stomachs of PP1 Cbx3 hypo/hypo pups. BAT is the main site of thermogenesis in neonatal mice and vascularization of this tissue is required because of the high oxygen demands of this process (Crandall et al. 1997; Lim et al. 2012) . The changes in vascularization of the intestines and BAT prompted us to examine defects in metabolism and energy homeostasis as the cause of the neonatal mortality because such defects may result in neonatal mortality in the absence of overt morphological abnormalities (Turgeon and Meloche 2009).
Cbx3
hypo/hypo neonates are hypoglycemic and have reduced amounts of glycogen Blood glucose measurements showed that PP1 Cbx3 hypo/hypo neonates had significantly lower blood glucose levels than wild-type or heterozygous pups, with concentrations of 2.1±0.6 mmol/L (N=9; range 3.1-<1.1 ) as compared to 3.1±0.5 mmol/L (N=17; range 3.8-2.1; P<0.006) respectively. In two of the PP1 Cbx3 hypo/hypo pups glucose levels were below the detection limit of 1.1 mmol/L. Moderately reduced blood glucose levels were also observed in the two PP8 Cbx3 hypo/hypo pups, even though they were found to have full stomachs upon dissection, BAT, placenta and liver. mRNA transcripts were measured on E19 (black, filled bars) and PP1 (cross-hatched) and compared to Cbx3 +/+ transcript levels that were normalized to 1.0 (empty bars). Significant expression changes are indicated by asterisks (*p<0.05; **p<0.01). Statistical significance was assessed by unpaired t-test. Number of animals analysed: BAT for ORO -hypo/hypo=6; +/+=6; BAT for gene expression -hypo/hypo=5; +/+=5 for E19 and hypo/hypo=3; +/+=4 for PP1; liver for PAS -hypo/hypo=6; +/+=6; liver for gene expression hypo/hypo=3; +/+=3 for E19 and hypo/hypo=4; +/+=2 for PP1; placenta for gene expression hypo/hypo=3; +/+=3. PCRs were repeated 3 times.
with 5.6 and 5.7 mmol/L (two Cbx3 hypo/hypo pups) compared to 6.8 (Cbx3 +/+ ) and 7.5 mmol/L (Cbx3 hypo/+ ) in control littermates.
Staining of livers for PAS showed that there was reduced glycogen in newborn (PP1) Cbx3 hypo/hypo (figure 4b) (N= 6) livers compared to wild-type (figure 4e) (N=6). There was no difference in PAS staining of PP1 hearts (not shown) indicating that the depletion of liver glycogen is likely to be a secondary consequence to the inability of Cbx3 hypo/hypo newborns to suckle and take on carbohydrate in the milk ( figure 1a and d) , which would be transported back to the liver via the intestines. This would also be consistent with the observation that depleted glycogen reserves were limited to postnatal livers because fetal (E19) Cbx3 hypo/hypo (N=6) and wild-type (N=6) livers showed no difference in PAS staining (C.f. figure 4c with 4f) .
Given the hypoglycemia and reduction in glycogen deposits in PP1 Cbx3
hypo/hypo livers we investigated mRNA transcript levels of three genes coding for enzymes active in glucose/ glycogen metabolism by qRT-PCR on days E19 and PP1. The genes were glycogen synthase (Gys2), glucose-6-phosphatase (G6pc) and phosphoenolpyruvate carboxykinase (Pck1). As shown in figure 4k Pck1 was up-regulated in Cbx3 hypo/hypo mutants at both E19 and PP1 by 1.4-and 2.3-fold respectively. G6pc transcript levels were also up-regulated 2.4-fold on PP1, but showed a moderate 0.8-fold down-regulation on E19 (figure 4k). There were no significant changes in expression of Gys2 (figure 4k).
hypo/hypo homozygotes are deficient in BAT lipid deposits
The finding that BAT vascularization is reduced in Cbx3 hypo/hypo homozygotes indicated that the function of this tissue might be impaired. We therefore decided to examine the histology and lipid content by HE and Oil red O staining of BAT from PP1 Cbx3 hypo/hypo and wild-type pups. HE revealed that BAT of Cbx3 hypo/hypo mutants exhibited a higher nuclear density that was likely due to reduced cell volume (C.f. figure 4g with 4h) . The difference in Oil Red O staining of PP1 Cbx3 hypo/hypo (N=9) BAT compared to wildtype or Cbx3 hypo/+ controls (N=9) was striking. Lipid was either absent or strongly reduced in Cbx3 hypo/hypo BAT (C.f. figure 4g with 4h) ; this strong reduction in lipid content could explain the decreased cell volume in Cbx3 hypo/hypo BAT. We next asked whether the reduction of lipid was also found prenatally. Accordingly, we stained BAT of E19 Cbx3 hypo/hypo fetuses with Oil Red O and showed that the lipid was also reduced in the BAT of E19 Cbx3 hypo/hypo fetuses (9 mutant vs. 7 wild-type or heterozygous) (C.f. figure 4i with figure 4j ). The prenatal depletion of lipid Cbx3 hypo/hypo BAT indicates that the depletion was not caused solely by the inability to suckle.
The abnormal development of BAT prompted us to investigate real time mRNA transcription of genes involved in lipid metabolism and BAT differentiation in Cbx3 hypo/hypo BAT. We measured mRNA transcripts of three genes involved in lipid metabolism, Pparg2 (Jones et al. 2005) , Srebf1 (Eberlé et al. 2004) and Hmgcs (Goldstein and Brown 1990 ). For BAT differentiation we measured mRNA transcripts for Prlr (Budge et al. 2002) , Igf2, Pgc1a (Wu et al. 1999) , Citrate synthase (Cs) (Kloosterboer et al. 1979 ) and Ucp1. We observed similar levels of mRNA transcripts for Pparg2 and Hmgcs while Sreb1 transcription was elevated in Cbx3 hypo/hypo BAT (figure 4k). Hmgcs is a target gene of SREBF1 protein (Horton et al. 2003) . The lack of any change in Hmgcs expression indicates that Hmgcs may be regulated independently of SREBF1 in BAT. Cs is a quantitative marker for mitochondria (Kloosterboer et al. 1979) indicating that the number of mitochondria is unlikely to be changed in Cbx3 hypo/hypo BAT. Prlr showed no change in expression but there was up-regulation of Igf2 in Cbx3 hypo/hypo BAT onE19 but not on PP1 (figure 4k). Notably, mRNA transcripts of BAT-specific thermogenic genes Pgc1a and Ucp1 were significantly reduced on both E19 and PP1 (figure 4k), with Ucp1 showing a marked 10-fold down-regulation on E19.
In addition to measuring specific transcripts in BAT we also investigated whether there was any effect of the Cbx3 hypo/hypo mutation on placental prolactin (Prl) mRNA levels. We were prompted to do this because the placenta expresses Prl and prolactin is known to be involved in BAT development (Budge et al. 2002) , so it was possible that changes in placental Prl expression could cause the changes in BAT. We also extended our investigation to measuring transcript levels of several members of the prolactin gene family (Wiemers et al. 2003) , including Prl3c1, Prl4a1, Prl7b1, Prl7c1 and Prl8a9. qRT-PCR showed that mRNA transcripts from the Prl gene were expressed at similar levels in E19 Cbx3 hypo/hypo and wild-type placentas (figure 4k). Expression of mRNAs from all other family members was significantly up-regulated in E19 Cbx3 hypo/hypo placentas (figure 4k). The up-regulation ranged from around a 2-fold increase for Prl4a1, Prl7c1 and Prl8a9 to 3-fold for Prl7b1 and 6-fold for Prl3c1.
Discussion
Mammalian Cbx genes have non-redundant functions (reviewed in Singh 2010). This was first shown for the Cbx1 gene where the proximate cause of the neonatal lethality of Cbx1 −/− mice was the inability of the lungs to inflate because of defective innervations of the diaphragm (Aucott et al. 2008) . Ablation of the Cbx5 gene results in a specific silencing defect within the T-cell lineage (Allan et al. 2012) hypo/hypo placental weights were statistically smaller than wild-type was on E13 and correlates with both reduced cell proliferation and nuclear density within the labyrinth of the placenta, which is the site of nutrient, gas and waste exchange between the fetal and maternal blood supplies (Watson and Cross 2005) . The weight disparity between Cbx3 hypo/hypo and wild-type was greatest between E14 and E16, thereafter the placenta appears to compensate for its small size; the disparity was narrowed but was never closed. One compensatory mechanism that began at around E14 was an increase in nuclear density within the labyrinth of Cbx3 hypo/hypo placentas. The increase in nuclear density was still manifested in E19 Cbx3 hypo/hypo placentas and might provide a compensatory mechanism to increase interface between the fetal and maternal blood supplies.
The 'catch-up' in Cbx3 hypo/hypo placental weight was not reflected in the trajectory of Cbx3 hypo/hypo fetal weights during development: there is no 'catch-up' in the weight of Cbx3 hypo/hypo fetuses during development. We did not find an increase in cell proliferation in Cbx3 hypo/hypo heart, lung or tongue. There was one exception in that Cbx3 hypo/hypo BAT exhibited increased cell proliferation compared to wildtype. Although unlikely to contribute significantly to overall fetal weight because of its small size the increased cell proliferation in Cbx3 hypo/hypo BAT may represent a compensatory mechanism in an organ that is important for early postnatal life: BAT is responsible for the rapid production of heat at birth (Cannon and Nedergaard 2004) .
Nutrient supply from the placenta to the fetus is not only dependent on the size of the placenta but also on its morphology, blood flow and the abundance of the various transport mechanisms. All three of these characteristics appear to be compromised in the Cbx3 hypo/hypo mutant placentas. We observed a morphological narrowing of the placental blood vessels in late gestation Cbx3 hypo/hypo placentas that is likely due to a reduction of the intracellular matrix surrounding the vessels; the smooth muscle appeared normal. Narrowing of placental blood vessels would reduce blood flow and thus nutrient exchange and exacerbate any problems in transport across the placenta. Our investigation of transport mechanisms was revealing. In E19 placentas there was downregulation of genes that promote placental growth such as the placenta-specific transcript of Igf2, Igf2P0, and Grb10. The reduced expression of Igf2P0 is of interest because it is known to be important for placental growth and placental transport through regulation of genes such as Slc38a2 that encode transporter proteins (Sferruzzi-Perri et al. 2011) . Notably, the mRNA transcripts of both glucose (Slc2a1 and Slc2a3) and amino-acid (Slc38a1 and Slc38a2) transporters were significantly reduced showing that placental transport function is likely to be compromised in Cbx3 hypo/hypo placentas. We directly tested transport capacity by measuring the cumulative transport of EFAs across Cbx3 hypo/hypo and wild-type placentas. EFA transport is strictly regulated and involves several protein classes, such as FA translocases and FA transport proteins (Duttaroy 2009 ). Our results indicated that there was likely to be a defect in placental transport in Cbx3 hypo/hypo placentas. Specifically, we found that Cbx3 hypo/hypo fetuses in one of two E13 litters showed a significant reduction in the EFA:NEFA ratio and the Cbx3 hypo/hypo heads of an E18 litter showed a reduced EFA:NEFA ratio.
The picture that emerges is that Cbx3 hypo/hypo placentas are affected first, with abnormalities observed in placental morphology, blood supply and transport. These defects are likely to contribute to the fetal growth restriction that follows. An important player is, we suggest, the placentaspecific Igf2P0 transcript. Down-regulation of the Igf2P0 transcript could set in motion the growth and transport defects we observe in the Cbx3 hypo/hypo placentas. A key experiment will be to test whether CBX3 protein binds the Igf2P0 gene, which would support a role for CBX3 in facilitating proper elongation of Igf2P0 transcript.
Loss of energy homeostasis in Cbx3
hypo/hypo neonates
The small Cbx3 hypo/hypo neonates show no overt morphological abnormalities. Reduced size cannot alone explain the severe postnatal mortality. For example, ablation of the Igf2P0 transcript is not associated with postnatal mortality despite Igf2P0 null newborns being even smaller than Cbx3 hypo/hypo newborns -69% (Igf2P0 null mutant) vs. 78% (Cbx3 hypo/hypo mutant). Other defects in Cbx3 hypo/hypo mutants must be involved in the postnatal mortality. From our results there are good candidates that could contribute to the postnatal mortality of Cbx3 hypo/hypo newborns. One of the observations was that there was a likely disruption of glucose/glycogen metabolism in Cbx3 hypo/hypo mutants. Any hypoglycemia would have been compounded by the lack of suckling of PP1 Cbx3 hypo/hypo pups that would in turn lead to depletion of liver glycogen reserves. The compensatory upregulation of G6pc on PP1was ineffectual because there were little glycogen reserves upon which the enzyme could act. The up-regulation of liver Pck1, whose product is the rate limiting step of gluconeogenesis from non-carbohydrate sources (Chakravarty et al. 2005) , on E19 and PP1 was also insufficient to alleviate the hypoglycemia. We also observed a dramatic depletion of lipid stores in BAT and the reduced expression of two BAT-specific thermogenic genes, Pgc1a and Ucp1. Pgc1a is involved in activation of the Ucp1gene in BAT (Puigserver et al. 1998) and, importantly, the UCP1 protein is responsible for non-shivering thermogenesis in BAT (Matthias et al. 2000) . We did not observe any changes in expression of the prolactin (Prl) gene in the placenta or of the gene encoding its cognate receptor (Prlr) in BAT, both of which are involved BAT differentiation (Budge et al. 2002; Viengchareun et al. 2008) . We did observe changes in placental expression in other members of the prolactin gene family but it is unclear what this means for BAT differentiation. Given the broad euchromatic distribution of CBX3 (Horsley et al. 1996) and its role in transcriptional elongation of mRNA transcripts (Vakoc et al. 2005; Hediger and Gasser 2006) , depletion of CBX3 is likely to have widespread effects on decreasing transcriptional elongation of many genes. Accordingly, CBX3 depletion may explain the down-regulation of mRNAs for growth regulators, Igf2P0 and Grb10, glucose (Slc2a1 and Slc2a3) and amino-acid (Slc38a1 and Slc38a2) transporters in the placenta. The dramatic reduction of the Ucp1 mRNA transcripts in BAT is of particular significance, especially in the context of the depleted lipid stores. This is because UCP1 protein is responsible for non-shivering thermogenesis in BAT (Matthias et al. 2000) . UCP1 increases the conductance of the inner mitochondrial membrane so that BAT mitochondria generate heat instead of ATP (Nicholls and Locke 1984) . There is also an essential requirement of long chain fatty acids (LCFA) in this process. UCP1 is a LCFA anion/H + symporter and has an absolute requirement for LCFA in order to function (Fedorenko et al. 2012) . Thus the dramatic decrease in transcription of Ucp1 and the almost complete loss of lipid stores would render the heat-generating capacity of Cbx3 hypo/hypo BAT practically negligible. The mechanism by which CBX3 protein activates Ucp1 expression may be as a constituent of the PRDM16 transcriptional complex (Seale et al. 2008) , which contains the histone H3K9 methyltransferase EHMT1 (Ohno et al. 2013) . Depletion of CBX3 could destabilize the PRDM16 transcriptional complex in a manner that has already been described after loss of EHMT1 protein (Ohno et al. 2013 ). Loss of PRDM16 or EHMT1 activity decreases Upc1 expression to 50% and 33% of wild-type levels respectively (Seale et al. 2008; Ohno et al. 2013) . By contrast Upc1 expression is reduced 10-fold in E19 Cbx3 hypo/hypo BAT indicating that defects in other regulatory mechanism(s) reduce Ucp1 expression. We suggest that inhibition of transcriptional elongation of Ucp1 and its activator, Pgc1a, might also contribute to the decrease of Ucp1 mRNA transcripts in Cbx3 hypo/hypo BAT.
4.3 A scenario for the severe attrition of Cbx3 hypo/hypo neonates
The severe postnatal mortality of Cbx3 hypo/hypo homozygotes is similar to that observed in newborn rats that have been subjected to experimental fetal growth restriction (FGR) (Cogneville et al. 1975 ). Cogneville and colleagues generated unilateral FGR by clamping the uterine artery of one uterine horn. Just as we observed for Cbx3 hypo/hypo mutants, the growth-restricted fetuses and newborn rats exhibited both reduced lipid stores in BAT and a severe postnatal mortality (Cogneville et al. 1975) . It was argued that since BAT is essential for non-shivering thermogenesis in altricial newborn rodents, the postnatal depletion of lipids in BAT would lead to rapid hypothermia, inability to suckle, hypoglycemia, followed by death. However, work on mice deleted for Prlr (prolactin receptor gene), which causes reduced formation of BAT (Viengchareun et al. 2008) , indicates that there is little requirement for BAT in postnatal survival in the mouse (Nadine Binart, personal communication), although, as expected, Prlr −/− pups do succumb more rapidly to cold exposure than wild-type mice (Viengchareun et al. 2008) .
Notwithstanding the observations with Prlr −/− mice, we are persuaded that the scenario for neonatal death described by Cogneville et al. (1975) is similar to that which brings about the death of Cbx3 hypo/hypo homozygotes. This is because Prlr −/− newborns are of normal size (Viengchareun et al. 2008) , unlike the Cbx3 hypo/hypo pups and FGR neonates (Cogneville et al. 1975) . The smaller Cbx3 hypo/hypo newborns would lose heat more rapidly compared to Prlr −/− newborns because of the former's greater surface-to-volume ratio (the 'square-cube law'; Haldane 1926) . Moreover, heat loss may be further compounded because, in addition to thermoregulation via BAT, thermoregulation in newborn altricial rodents has a behavioural component termed huddling (Alberts 1978; Sokoloff and Blumberg 2001; Harshaw and Alberts 2012) . Huddling close to littermates is protective against the rapid heat loss that occurs during the brief exposure to cool ambient temperatures that isolated pups experience when the dam leaves the nest (Harshaw and Alberts 2012) . Notably, in a huddle of newborns there is competition between pups and pups with functional BAT thermogenesis tend to avoid contact with pups whose BAT thermogenesis is blocked (Sokoloff and Blumberg 2001) . Given that BAT development is abnormal in the smaller-than-normal Cbx3 hypo/hypo newborns, heat loss is likely to be further exacerbated by the mutants being pushed to the periphery of the nest where they do not experience the thermoregulatory benefit of huddling.
A scenario for the postnatal mortality is that Cbx3 hypo/hypo mutants are born small and hypoglycemic, largely due to abnormalities in placental morphology, blood supply and transport. After birth, hypothermia sets in due to defective BAT-dependent non-shivering thermogenesis and the lack of huddling. The hypoglycemia is further compounded by an inability to suckle and depletion of glycogen reserves. These defects reinforce each other and are severally necessary and jointly sufficient in bringing about the demise of the majority of Cbx3 hypo/hypo newborns.
